A New Method to Avoid the Basic Problem of Drug Resistance in Chemotherapy of Cancer |
From inside the book
Results 1-3 of 10
Page 1
... chemotherapy of human cancer have been in vain . At the moment there is not one chemotherapeutic agent which has a definite and lasting beneficial effect in the treatment of human cancer . Lists A and B are tabulations of all those ...
... chemotherapy of human cancer have been in vain . At the moment there is not one chemotherapeutic agent which has a definite and lasting beneficial effect in the treatment of human cancer . Lists A and B are tabulations of all those ...
Page 4
... chemotherapy of human cancer have used those substances which have shown an inhibitory or necrotising effect on transplanted or grafted tumors in animals only . Most of these substances exerted only a slight inhibitory effect , even on ...
... chemotherapy of human cancer have used those substances which have shown an inhibitory or necrotising effect on transplanted or grafted tumors in animals only . Most of these substances exerted only a slight inhibitory effect , even on ...
Page 71
... chemotherapy of human cancer by means of sequential use ( one after the other ) of a plurality of compounds . 2. Substances which have exerted a temporary , initial beneficial effect on human cancer should be used ( see lists A and B ) ...
... chemotherapy of human cancer by means of sequential use ( one after the other ) of a plurality of compounds . 2. Substances which have exerted a temporary , initial beneficial effect on human cancer should be used ( see lists A and B ) ...
Other editions - View all
Common terms and phrases
6-mercaptopurine Aboul-Nasr Abstr acid Acta Alanine Amer AMINOPTERIN Approaches to tumor Arch Arsphenamine Atoxyl Auler authors mentioned Proposed belge Biol BLUMENTHAL F Braunsteiner Brit Bull Burchenal Cancer Cancer Congress Cancer Res Chemioter chemotherapy chemotherapy of cancer Chir Choline cited by Wolff clin COLCHICINE Coley's toxins colloidal combination compounds Congress against Cancer Domagk dosage drug resistance Dtsch Endicott Farber franç Gellhorn Gynec Heilmeyer Hộp HUANT human cancer IIIB Initial dose intratumoral ital KARNOFSKY D. A. Klin Krebsarzt Krebsforsch Lancet Larionov Lewin LOEB LOESER lymphatic system MAISIN mentioned in list mentioned Proposed dose Meythaler-Handel Minerva Münch N. Y. Acad NITROGEN MUSTARD OCHSNER orally daily PAOLINO Paris Pirwitz possible s.c. Presse méd Pribilla Proc ROOSEN RUBENS-DUVAL Schulten Segaloff selenium Silicic acid sodium Strahlentherapie Surg THURSZ TODD A. T. Torino Total dose treatment tumor tumor chemotherapy Turner ULLMAN VASSILIADIS Wien Wright J. C. Wschr